At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Jun 8, 2026 at 18:07 ET
A cluster of insider selling at Neurocrine Biosciences, totaling ~$4.5M over a week, is dominated by C-suite officers exercising options and selling shares. While the dollar value is modest relative to the $16.5B market cap (~0.03%), the concentration of senior executives (CMO, CHRO, CSO, CRO) selling at similar times warrants attention, though the sales are largely tied to option exercises and tax withholding, reducing their informational signal.
- Four insiders sold shares totaling ~$4.53M in a 7-day window (May 29–June 4, 2026).
- Sales include C-suite: Chief Medical Officer, Chief Human Resources Officer, Chief Scientific Officer, and Chief Regulatory Officer.
- Total sales represent ~0.03% of NBIX's $16.5B market cap, well below the 0.1% materiality threshold.
- Most sales were preceded by option exercises (non-cash) or tied to tax withholding, suggesting liquidity-driven rather than informational selling.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access